image
Blueprint Medicines Corporation BPMC
Healthcare - Biotechnology - NASDAQ - US
Watchlist
$ 88.69
-7.28 %
$ 5.63 B
Market Cap
-42.85
P/E
INCOME STATEMENT
249 M REVENUE
22.22%
Growth Rates
1Year 22.22%
3Years -32.02%
5Years 41.14%
7Years 36.83%
10Years 0.00%
-486 M OPERATING INCOME
11.47%
Growth Rates
1Year 11.47%
3Years -37.67%
5Years -14.51%
7Years -30.96%
10Years -37.07%
-507 M NET INCOME
9.06%
Growth Rates
1Year 9.06%
3Years -37.77%
5Years -16.46%
7Years -32.03%
10Years -37.55%
EFFICIENCY
Earnings Waterfall Blueprint Medicines Corporation
image
Revenue 249 M
Cost Of Revenue 12.8 M
Gross Profit 237 M
Operating Expenses 723 M
Operating Income -486 M
Other Expenses 20.7 M
Net Income -507 M

Income Statement

Millions
Dec-2023 Dec-2022 Dec-2021 Dec-2020 Dec-2019 Dec-2018 Dec-2017 Dec-2016 Dec-2015 Dec-2014 Dec-2013
REVENUE
Revenue 249.4 204.0 180.1 793.7 66.5 44.5 21.4 27.8 11.4 0 0
GROSS PROFIT
Cost Of Revenue 12.8 17.8 17.9 0.4 0 243.6 144.7 81.1 48.6 31.8 15.9
Gross Profit 236.6 186.2 162.1 793.3 66.5 (199.1) (123.3) (53.4) (37.2) (31.8) (15.9)
OPERATING INCOME
Operating Expenses 722.9 723.7 804.1 484.6 427.8 291.5 172.7 100.3 63.0 39.7 21.0
Selling, General and Administrative Expenses 295.1 237.4 195.3 157.7 96.4 47.9 28.0 19.2 14.5 7.9 5.1
Research and Development Expenses 427.7 477.4 601.0 326.9 331.4 243.6 144.7 81.1 48.6 31.8 15.9
Operating Income (486.3) (549.3) (648.5) 302.1 (366.6) (247.0) (149.5) (73.6) (53.0) (39.8) (20.8)
PRE-TAX INCOME
Interest Income Expense 0 16.8 0 0 13.7 73 K 0.2 0.5 0.7 0.5 0.1
Total Other Income (19.7) (14.8) 0.9 6.2 13.6 10.4 3.1 82 K (1.1) (0.6) 88 K
Pre-Tax Income (506.0) (552.3) (641.1) 314.9 (347.7) (236.6) (148.1) (72.5) (52.8) (40.3) (20.9)
NET INCOME
Tax Provision 1.0 5.2 3.0 1.1 (19.0) 10.5 2.0 (0.6) (0.7) 0.4 0.4
Net Income (507.0) (557.5) (644.1) 313.9 (328.7) (236.6) (148.1) (72.5) (52.8) (40.3) (20.9)
EPS 8.37 9.35 11 5.76 6.87 5.39 3.92 2.64 2.89 3.08 1.6